GE rides gene therapy wave with ready-made viral drug factories
April 17, 2018 at 07:00 AM EDT
LONDON, April 17 (Reuters) - General Electric is raising its bet on biotechnology with the launch of prefabricated manufacturing units for producing virus-based gene and cell therapies, novel anti-cancer treatments and vaccines.